

Cover Story
Free
In recent years, Vinay Prasad, a young hematologist–oncologist at Oregon Health and Science University, has emerged as a premier critic of new directions in cancer medicine.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- “There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti
- Antibody halts triple-negative breast cancer in preclinical models
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- House passes three-year extension of ACA subsidies with bipartisan support
















